ATE324114T1 - Isolierung der mikrodomänen von kaveolae und gpi verankerten proteinen - Google Patents

Isolierung der mikrodomänen von kaveolae und gpi verankerten proteinen

Info

Publication number
ATE324114T1
ATE324114T1 AT96931461T AT96931461T ATE324114T1 AT E324114 T1 ATE324114 T1 AT E324114T1 AT 96931461 T AT96931461 T AT 96931461T AT 96931461 T AT96931461 T AT 96931461T AT E324114 T1 ATE324114 T1 AT E324114T1
Authority
AT
Austria
Prior art keywords
gpi
anchored proteins
microdomains
caveolae
pellicle
Prior art date
Application number
AT96931461T
Other languages
English (en)
Inventor
Jan E Schnitzer
Original Assignee
Beth Israel Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/582,917 external-priority patent/US5776770A/en
Application filed by Beth Israel Hospital filed Critical Beth Israel Hospital
Application granted granted Critical
Publication of ATE324114T1 publication Critical patent/ATE324114T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1275—Lipoproteins or protein-free species thereof, e.g. chylomicrons; Artificial high-density lipoproteins [HDL], low-density lipoproteins [LDL] or very-low-density lipoproteins [VLDL]; Precursors thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Electron Sources, Ion Sources (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Preparing Plates And Mask In Photomechanical Process (AREA)
AT96931461T 1995-09-08 1996-09-05 Isolierung der mikrodomänen von kaveolae und gpi verankerten proteinen ATE324114T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US345395P 1995-09-08 1995-09-08
US08/582,917 US5776770A (en) 1995-09-08 1996-01-04 Isolation and uses of caveolae
US1830196P 1996-05-24 1996-05-24
US1879196P 1996-05-31 1996-05-31

Publications (1)

Publication Number Publication Date
ATE324114T1 true ATE324114T1 (de) 2006-05-15

Family

ID=27485284

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96931461T ATE324114T1 (de) 1995-09-08 1996-09-05 Isolierung der mikrodomänen von kaveolae und gpi verankerten proteinen

Country Status (8)

Country Link
US (1) US6255457B1 (de)
EP (1) EP0848614B1 (de)
JP (2) JPH11514348A (de)
AT (1) ATE324114T1 (de)
AU (1) AU705945B2 (de)
CA (1) CA2228604A1 (de)
DE (1) DE69636074T2 (de)
WO (1) WO1997009055A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040115128A1 (en) * 1995-09-08 2004-06-17 Schnitzer Jan E. Targeting endothelium for tissue-specific delivery of agents
USRE38490E1 (en) 1995-11-16 2004-04-06 Baylor College Of Medicine Method for identifying metastatic sequences
USRE38392E1 (en) 1996-01-30 2004-01-20 Baylor College Of Medicine Method for identifying metastatic sequences
AU734476B2 (en) 1997-11-05 2001-06-14 Baylor College Of Medicine Sequences for targeting metastatic cells
US6545139B1 (en) 1998-03-13 2003-04-08 Baylor College Of Medicine DNA sequence encoding the p99 gene and kits for the detection of neoplasia
US6737516B1 (en) * 1998-12-09 2004-05-18 Jan E. Schnitzer Immunoisolation of caveolae
CA2400172C (en) * 2000-02-28 2010-04-20 Genesegues, Inc. Nanocapsule encapsulation system and method
US7462491B2 (en) 2002-01-31 2008-12-09 Baylor College Of Medicine Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin
US20040038303A1 (en) * 2002-04-08 2004-02-26 Unger Gretchen M. Biologic modulations with nanoparticles
US20050054088A1 (en) * 2002-11-05 2005-03-10 Rahbar Amir Mikel Method of separating plasma membrane proteins
EP1730190A4 (de) * 2004-02-11 2008-07-23 Univ Virginia Hemmung von cav3-isoformen und der &25b-splice-varianten zur diagnose und behandlung von krebs
CA2572453A1 (en) * 2004-06-02 2005-12-15 Sidney Kimmel Cancer Center Imaging and therapeutic agents targeting proteins expressed on endothelial cell surface
AU2005249541B2 (en) 2004-06-02 2010-02-25 Jan E. Schnitzer Vascular targets for detecting, imaging and treating neoplasia or neovasculature
CA2681795A1 (en) * 2006-03-24 2007-10-04 Gencia Corporation Synthetic lipid rafts and methods of use
US8282930B2 (en) 2007-09-24 2012-10-09 The University Of Queensland Molecular delivery vehicle
SG183114A1 (en) 2010-03-01 2012-09-27 Tau Therapeutics Llc Cancer diagnosis and imaging
KR20170054429A (ko) 2014-09-03 2017-05-17 제네세규스 인코포레이티드 치료용 나노입자 및 관련 조성물, 방법, 및 시스템

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602005A (en) * 1989-03-03 1997-02-11 The University Of Virginia Alumni Patents Foundation Primate intra-acrosomal sperm antigen for use in a contraceptive vaccine
US5281700A (en) 1992-08-11 1994-01-25 The Regents Of The University Of California Method of recovering endothelial membrane from tissue and applications thereof

Also Published As

Publication number Publication date
EP0848614B1 (de) 2006-04-26
AU705945B2 (en) 1999-06-03
WO1997009055A1 (en) 1997-03-13
JP2008189674A (ja) 2008-08-21
JPH11514348A (ja) 1999-12-07
DE69636074D1 (de) 2006-06-01
EP0848614A1 (de) 1998-06-24
AU7013796A (en) 1997-03-27
US6255457B1 (en) 2001-07-03
CA2228604A1 (en) 1997-03-13
DE69636074T2 (de) 2007-05-03

Similar Documents

Publication Publication Date Title
ATE324114T1 (de) Isolierung der mikrodomänen von kaveolae und gpi verankerten proteinen
DE69637867D1 (de) Verfahren zur Kontrollierung der Sialylierung von durch Säugetierzellkultur hergestellten Proteinen
DE69632266T2 (de) Polymermaterial für elektrolytische membranen von brennstoffzellen
DE69630570D1 (de) Verfahren zur Herstellung von gestützten Membranen
DK494688A (da) Fremgangsmaade til opbevaring eller dyrkning af celler og poroes, uorganisk baere-membran og apparat dertil
DK165221C (da) Belagte transplantater og fremgangsmaade til belaegning af disse
AU5055593A (en) Antibodies specific for HIV
ATE175132T1 (de) Verfahren zur herstellung von mikrokapseln
DK1137808T3 (da) Fremgangsmåde til fremstilling af rekombinante celler
DE60232234D1 (de) Verfahren zur kultivierung von circovirus
ATE15973T1 (de) Verfahren zur fraktionierung von blutplasma.
ATE227579T1 (de) Verfahren zur herstellung von makrophagen und ausrüstungen zur durchführung dieses verfahrens
TR199800947T2 (xx) Dinamik sistemler i�in uyarlanabilir kalman filtreleme y�ntemi.
DE69433822D1 (de) Humane epithelzellinien der leber
DE69630955D1 (de) Immortalisierung bzw. desimmortalisierung von zellen
EP1037603A4 (de) Virus mit membranmutationen für ein witsspektrum und deren verwendung als vakzinsubstrat
BR9612115A (pt) Inibidor de proliferação de célula endotelial e processo de uso
DE68908223D1 (de) Verfahren zur herstellung von sehr reiner, dichter grossteiliger kieselsaeure.
WO2004056976A3 (en) Process for coating cell-culture support
WO1998006827A3 (en) Method for immortalizing cells
ATE196652T1 (de) In kunstlisches rekombinantes substrat ragg-1 und nativem aggrecan zum studium der proteolytischen wirkung von 'aggrecanase' in zellkultursystemen
DK0876532T3 (da) Fremgangsmåde til fremstilling af en impermeabel membran og tagbeklædning og produkter opnået ved hjælp af fremgangsmåden
PT1019526E (pt) Metodo para determinar actividade de canal ionico de uma substancia
ATE522604T1 (de) Verfahren zur herstellung von proteinen durch elektropulsierung
DK526889A (da) Apparat til gennemfoerelse af membranskilleprocesser

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties